CN Patent

CN102325539A — 基于酰胺的胰高血糖素超家族肽前药

Assigned to Indiana University Research and Technology Corp · Expires 2012-01-18 · 14y expired

What this patent protects

本发明提供胰高血糖素超家族肽的前药制剂，其中通过使二肽经由酰胺键与胰高血糖素超家族连接来修饰胰高血糖素超家族肽。本文公开的前药具有延长的半寿期，并且在生理条件下通过由化学不稳定性驱动的非酶促反应转化为活性形式。

USPTO Abstract

本发明提供胰高血糖素超家族肽的前药制剂，其中通过使二肽经由酰胺键与胰高血糖素超家族连接来修饰胰高血糖素超家族肽。本文公开的前药具有延长的半寿期，并且在生理条件下通过由化学不稳定性驱动的非酶促反应转化为活性形式。

Drugs covered by this patent

Patent Metadata

Patent number
CN102325539A
Jurisdiction
CN
Classification
—
Expires
2012-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Indiana University Research and Technology Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.